Varicella Seroprevalence in Healthcare Workers at a Medical Center Following Changes in National and Local Hospital Vaccination Policies

被引:1
|
作者
Tsou, Meng-Ting [1 ]
Shao, Hsin-Hui [1 ]
机构
[1] Mackay Mem Hosp, Dept Family Med, Taipei 10449, Taiwan
关键词
healthcare worker; seroprevalence; varicella; immunization; ZOSTER-VIRUS INFECTION; PREDICTIVE-VALUE; HISTORY; ANTIBODIES; TAIWAN; STAFF;
D O I
10.3390/ijerph16193544
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Varicella seroprevalence in healthcare workers at a tertiary care hospital in Taiwan was assessed following the inclusion of varicella zoster vaccination in the national vaccination schedule in 2004 and was made a hospital policy in 2008. Methods: Seroprevalence data were extracted from records of pre-employment health check-ups performed between 2008 and 2018 at a single medical center. Staff with complete medical records and anti-varicella zoster virus immunoglobulin G (VZV IgG) titers were included. Sex and age group differences in terms of geometric mean titer (GMT) were compared using analysis of variance and chi-squared tests. The significance of the correlation between age and the anti-VZV IgG titer was tested by linear regression. The odds of significant associations among age, sex, vocation, and the years of national and hospital adoption of vaccination were determined using univariate and multivariate analyses. p < 0.05 was considered statistically significant. Results: Of the 7314 eligible participants, 5625 (76.90%) were women, and the mean patient age was 26.80 +/- 8.00 years. The lowest VZV-positivity rates were in 18-20-year-old women (85.16%; GMT, 362.89 mIU/mL) and men (87.59%; GMT, 288.07 mIU/mL). VZV positivity increased with age (p < 0.001). Participants born before 2002 were more likely to be seropositive than those born after 2003 (odds ratio, 2.51 vs. 1.0; p < 0.001). The lowest seropositive rate was found in the nursing staff (88.91%; 95% confidence interval, 87.74%-90.05%). Varicella vaccine boosters have been required at pre-employment health check-ups since 2008 if anti-VZV antibodies were not detectable. A follow-up evaluation found marginal significant differences in the odds ratios of seropositivity after 2007 (p = 0.052), especially in 2008 and 2014 (p < 0.05) after the hospital policy launched. Conclusions: Despite public health efforts, a small number of healthcare workers were inadequately protected, and antibody titers were lower than required to maintain herd immunity. For effective prevention of nosocomial infection, VZV IgG status should be documented for all HCWs, and susceptible HCWs should be vaccinated to avoid outbreaks. Pre-employment screening and vaccination have increased immunity and need to be conducted to ensure protection of vulnerable patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Analysis of the Economic Burden of COVID-19 on the Workers of a Teaching Hospital in the Centre of Italy: Changes in Productivity Loss and Healthcare Costs Pre and Post Vaccination Campaign
    Di Fabio, Sara
    La Torre, Giuseppe
    VACCINES, 2023, 11 (12)
  • [42] Assessment of safety and adverse events following COVID-19 vaccination and their predictors in first 30 days among healthcare workers of a tertiary care teaching hospital in North India
    Bashar, M. D. Abu
    Kamble, Bhushan
    Kumar, Sampath
    Nandekar, Sanket, V
    Mathur, Sharad Kumar
    VACCINE: X, 2024, 19
  • [43] Comparison of SARS-CoV-2 anti-spike IgG and anti-nucleoprotein IgG seroprevalence amongst a pre-vaccine cohort of healthcare workers at an academic medical center in Boston, Massachusetts
    Cole, Manisha
    Dodge, Maura C.
    Duffy, Elizabeth R.
    Osterland, Jordyn N.
    Gawel, Susan H.
    Ye, Lei
    Cena, Kyle de la
    Ragan, Elizabeth J.
    Weber, Sarah E.
    Schechter-Perkins, Elissa M.
    Bouton, Tara C.
    Jacobson, Karen R.
    Andry, Chris
    Kataria, Yachana
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [44] Comparison of SARS-CoV-2 anti-spike IgG and anti-nucleoprotein IgG seroprevalence amongst a pre-vaccine cohort of healthcare workers at an academic medical center in Boston, Massachusetts
    Cole, Manisha
    Dodge, Maura C.
    Duffy, Elizabeth R.
    Osterland, Jordyn N.
    Gawel, Susan H.
    Ye, Lei
    de la Cena, Kyle
    Ragan, Elizabeth J.
    Weber, Sarah E.
    Schechter-Perkins, Elissa M.
    Bouton, Tara C.
    Jacobson, Karen R.
    Andry, Chris
    Kataria, Yachana
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2022, 7
  • [45] Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: Prospective cohort study from a hospital in Argentina
    Gentile, A.
    Castellano, V. E.
    Pacchiotti, A.
    Weinberger, N.
    Menendez, S. Diana
    del Pino, M.
    Carciofi, G.
    Lamy, P.
    Mistchenko, A. S.
    VACCINE: X, 2022, 11
  • [46] Impact of Changes to the National Healthcare Safety Network (NHSN) Definition on Catheter-Associated Urinary Tract Infection (CAUTI) Rates in Intensive Care Units at an Academic Medical Center
    Advani, Sonali D.
    Lee, Rachael A.
    Schmitz, Mariann
    Camins, Bernard C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (05): : 621 - 623
  • [47] Impact of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination on the incidence of coronavirus disease 2019 (COVID-19) among healthcare workers at an academic medical center in Vermont
    Noyes, Cindy D.
    Raymond, Monica J.
    Wojewoda, Christina M.
    Alston, W. Kemper
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
  • [48] The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay
    Maple, P. A. C.
    Haedicke, J.
    Quinlivan, M.
    Steinberg, S. P.
    Gershon, A. A.
    Brown, K. E.
    Breuer, J.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (11): : 2345 - 2353
  • [49] Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy)
    Isgro, Maria Antonietta
    Trillo, Giusy
    Russo, Luigi
    Tornesello, Anna Lucia
    Buonaguro, Luigi
    Tornesello, Maria Lina
    Miscio, Leonardo
    Normanno, Nicola
    Bianchi, Attilio Antonio Montano
    Buonaguro, Franco Maria
    Cavalcanti, Ernesta
    INFECTIOUS AGENTS AND CANCER, 2022, 17 (01)
  • [50] Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
    Maria Antonietta Isgrò
    Giusy Trillò
    Luigi Russo
    Anna Lucia Tornesello
    Luigi Buonaguro
    Maria Lina Tornesello
    Leonardo Miscio
    Nicola Normanno
    Attilio Antonio Montano Bianchi
    Franco Maria Buonaguro
    Ernesta Cavalcanti
    Infectious Agents and Cancer, 17